George H. Rothblat, PhD George H. Rothblat, PhD, is a researcher with the Division of Gastroenterology, Hepatology and Nutrition at The Children's Hospital of Philadelphia. Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467) Education and Training Undergraduate DegreeBS in Bacteriology - University of Connecticut, Mansfield, CT Graduate DegreePhD in Medical Microbiology - University of Pennsylvania, Philadelphia, PA Titles and Academic Titles Senior Member, Joseph Stokes Research InstituteResearch Professor of Pediatrics, University of Pennsylvania School of Medicine Publications Papers2012 G.L. Weibel, M.R. Joshi, W.G. Jerome, S.R. Bates, K.J. Yu, M.C. Phillips, G.H. Rothblat: "Cytoskeleton disruption in J774 macrophages: consequences for lipid droplet formation and cholesterol flux" Biochim Biophys Acta 1821(3): 464-72, Mar 2012. R.S. Rosenson, H.B. Brewer, Jr., W.S. Davidson, Z.A. Fayad, V. Fuster, J. Goldstein, M. Hellerstein, X.C. Jiang, M.C. Phillips, D.J. Rader, A.T. Ramaley, G.H. Rothblat, A.R. Tall, L. Yvan-Charvet: "Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport" Circulation 125(15): 1905-19, Apr 17 2012. W.R. Lagor, D.W. Fields, S.A. Khetarpal, A. Kumaravel, W. Lin, N. Weintraub, K. Wu, S.F. Hamm-Alvarex, D. Drazul-Schrader, M. de la Llera-Moya, G.H. Rothblat, D.J. Rader: "The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice" PLoS One 7(2): e31616, 2012. BooksRothblat GH, Cristofalo VJ: Growth, Nutrition, and Metabolism of Cells in Culture, (Vol. 1, 2, and 3). G. H. Rothblat and V.J. Cristofalo (eds.). Academic Press 1997. Chapters 2010 G. Kellner-Weibel, M. de la Llera-Moya, S. Sankaranarayanan, G.H. Rothblat: "In Vitro Studies and Mass Flux of Cholesterol Between Serum and Macrophages," High Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease. E. Schaefer (eds.). Springer, New York, Page: 83-88, 2010. G. H. Rothblat, M.C. Phillips: "High Density Lipoprotein (HDL) Heterogeneity and Function in Reverse Cholesterol Transport," Current Opinion in Lipidology 21(3): 229-238, June 2010. 1998 Phillips MC, Gillotte KL, Haynes MP, Johnson WJ, Lund-Katz S, Rothblat GH: Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes. Atherosclerosis 137: S13-S17, 1998. Phillips MC, Gillotte K, Lund-Katz S, Johnson W, Rothblat GR: High-density lipoproteins and cellular cholesterol efflux. Atherosclerosis XI-Proceedings of the XIth International Symposium on Atherosclerosis. B. Jacotot, D. Mathe and J.-C. Fruchart (eds.). Elsevier Science, Singapore, Page: 861-865, 1998. 1995 Rothblat GH, Yancey P, Davidson WS, Atger V, Lund-Katz S, Johnson WJ, de la Llera-Moya M, Phillips MC: Cholesterol efflux from cells in culture: Studies with lipid-free acceptors, reconstituted particles and whole serum. Cardiovascular Disease 2. Cellular and Molecular Mechanisms, Prevention and Treatment. L.L. Gallo (eds.). Plenum Press, New York, Page: 89-96, 1995. 1967 Rothblat, G.H., R. Hartzell, H. Mialhe, and D. Kritchevsk: Cholesterol metabolism in tissue culture cells. Lipid Metabolism in Tissue Culture Cells G.H. Rothblat and D. Kritchevsky (eds.). Wistar Institute Press, Philadelphia, Page: 129-149, 1967. Awards and Honors 1989, Pfizer Traveling Fellow1988, Recipient Johnson & Johnson, Focused Giving Award1970-1975, Established Investigator, American Heart Association1966-1969, NIH Special Research Fellowship Editorial and Academic Positions Academic and institutional committees 2001-present, Stokes Investigators Committee Leadership and Memberships Memberships in professional organizations 1989-present, American Association for the Advancement of Science1970-present, American Heart Association 1995-present, Fellow, Council on Arteriosclerosis Patient Experience Ratings About the Patient Experience Rating System The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.